Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants

Siu, Y. K.; Ng, P. C.; Fung, S. C. K.; Lee, C. H.; Wong, M. Y.; Fok, T. F.; So, K. W.; Cheung, K. L.; Wong, W.; Cheng, A. F. B.
September 1998
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep1998, Vol. 79 Issue 2, pF105
Academic Journal
No abstract available.


Related Articles

  • Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Ng, P. C.; So, K. W.; Fung, K. S. C.; Lee, C. H.; Fok, T. F.; Wong, E.; Wong, W.; Cheung, K. L.; Cheng, A. F. B. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;May2001, Vol. 84 Issue 3, pF177 

    Aim--To evaluate the effectiveness of oral erythromycin as a prokinetic agent for the treatment of moderately severe gastrointestinal dysmotility in preterm very low birthweight infants. Methods--A prospective, double blind, randomised, placebo controlled study in a tertiary referral centre of a...

  • Probiotics reduce the risk of necrotising enterocolitis (NEC) in preterm infants. Embleton, Nicholas; Berrington, Janet E. // Evidence Based Medicine;Dec2013, Vol. 18 Issue 6, p219 

    The authors reflect on the study titled "Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis" by L.A. Fernández-Carrocera and colleagues published in a 2013 issue of the...

  • An ‘all-human' diet decreases days of parenteral nutrition compared with formula in premature infants. Underwood, Mark A. // Evidence Based Medicine;Aug2014, Vol. 19 Issue 4, p142 

    The author discusses aspects of the study "Randomised trial of exclusive human milk versus preterm formula diets in extremely premature infants," by E. A. Cristofalo and colleagues. Topics include the incidence of necrotising enterocolitis (NEC) among premature infants, the use of pasteurised...

  • Nosocomial infection in small for gestational age newborns with birth weight <1500 g: a multicentre analysis. Bartels, Dorothee B.; Schwab, Frank; Geffers, Christine; Poets, Christian F.; Gastmeier, Pefra // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Nov2007, Vol. 92 Issue 6, pF449 

    Objective: To investigate whether preterm newborns who are small for gestational age are at increased risk of nosocomial infections and necrotising enterocolitis. Design, setting and subjects: The German national surveillance system for nosocomial infection in very low birthweight infants uses...

  • Cost of morbidities high in VLBW infants.  // PharmacoEconomics & Outcomes News;9/15/2012, Issue 662, p6 

    The article discusses the results of a study which shows that an increase in the costs of care is associated with the presence of any of four potentially preventable morbidities in very low birthweight (VLBW) including brain injury, necrotising enterocolitis (NEC) and late-onset sepsis.

  • Budesonide Inhalation Suspension: A Review of its Use in Infants, Children and Adults with Inflammatory Respiratory Disorders. Hvizdos, K.M.; Jarvis, B. // Drugs;Nov2000, Vol. 60 Issue 5, p1141 

    Budesonide, a topically active corticosteroid, has a broad spectrum of clinically significant local anti-inflammatory effects in patients with inflammatory lung diseases including persistent asthma. In infants and young children with persistent asthma, day- and night-time symptom scores, and the...

  • Bacillus clausii for Prevention of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial. Tewari, Vishal Vishnu; Dubey, Sachin Kumar; Gupta, Girish // Journal of Tropical Pediatrics;Oct2015, Vol. 61 Issue 5, p377 

    Background Of the Study: Preterm infants are managed with antibiotics for sepsis, including suspected or probable sepsis. This leads to a delayed and abnormal colonization of the gut with potentially pathogenic organisms and a microbiome, which lacks biodiversity and increases the...

  • A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities. Gokmen, T; Oguz, S S; Bozdag, S; Erdeve, O; Uras, N; Dilmen, U // Journal of Perinatology;Feb2012, Vol. 32 Issue 2, p123 

    Objective:To compare the effectiveness of oral erythromycin versus ursodeoxycholic acid (UDCA) treatment in preventing feeding intolerance and liver function abnormalities.Study Design:A prospective, double blind, randomized, controlled trial in which three groups of preterm infants (birth...

  • Antifungal prophylaxis for very low birthweight infants: UK national survey. Clerihew, L.; McGuire, W. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;May2008, Vol. 93 Issue 3, pF238 

    In a UK-wide survey, 28% of neonatal units reported using systemic or topical/oral antifungal prophylaxis for very low birthweight infants. Systemic prophylaxis is targeted to extremely preterm infants with additional risk factors for invasive fungal infection. Currently, there seems to be...

  • Probiotics for preterm neonates: parents' perspectives and present prevalence. Sesham, Rajesh; Oddie, Sam; Embleton, Nicholas D.; Clarke, Paul // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2014, Vol. 99 Issue 4, pF345 

    In this article, the author discusses role of probiotics in preterm infants which decreases risk of necrotising enterocolitis (NEC) or death with the help of meta-analysis. The author mentions randomized controlled trials with 5000 very low birth weight (VLBW) infants which not shown any adverse...


Read the Article


Sign out of this library

Other Topics